Replies to post #101377 on Biotech Values

[acgood]

On one of the recent conference calls, Wheeler also made a statement to the effect that the program costs would end up being shared proportionally in the same ballpark as the revenue split. This would add credence to the ~50/50 split as a reasonable estimate